TY  - JOUR
AU  - Abtan, Jeremie
AU  - Bhatt, Deepak L
AU  - Elbez, Yedid
AU  - Ducrocq, Gregory
AU  - Goto, Shinya
AU  - Smith, Sidney C
AU  - Ohman, E Magnus
AU  - Eagle, Kim A
AU  - Fox, Kim
AU  - Harrington, Robert A
AU  - Leiter, Lawrence A
AU  - Mehta, Shamir R
AU  - Simon, Tabassome
AU  - Petrov, Ivo
AU  - Sinnaeve, Peter R
AU  - Pais, Prem
AU  - Lev, Eli
AU  - Bueno, Hector
AU  - Wilson, Peter
AU  - Steg, Philippe Gabriel
PY  - 2023
DO  - 10.1016/j.ijcard.2022.10.132
UR  - http://hdl.handle.net/20.500.12105/15933
AB  - THEMIS is a double-blind, randomized trial of 19,220 patients with diabetes mellitus and stable coronary artery disease (CAD) comparing ticagrelor to placebo, in addition to aspirin. The present study aimed to describe the proportion of patients...
LA  - eng
PB  - Elsevier
KW  - Coronary Artery Disease
KW  - Percutaneous Coronary Intervention
KW  - Diabetes Mellitus, Type 2
KW  - Myocardial Infarction
KW  - Stroke
KW  - Humans
KW  - Ticagrelor
KW  - Aspirin
KW  - Outcome Assessment, Health Care
KW  - Treatment Outcome
KW  - Platelet Aggregation Inhibitors
TI  - External applicability of the Effect of ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) trial: An analysis of patients with diabetes and coronary artery disease in the REduction of Atherothrombosis for Continued Health (REACH) registry.
TY  - journal article
ER  -